FADD and colon carcinoma: In order to obtain the optimal time and concentration-dependent intracellular uptake and signaling of TAT-FADD, we first treated the colon carcinoma HCT116 cells with 1, 2.5, 5, 10, and 20 μM of TAT-FADD conjugate for various time points.